Heyuan Niu

Dr. Heyuan Niu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZZZi-Huan Zhang
Zi-Huan Zhang
DLDuo Li
Duo Li
TWTianxiao Wang
Tianxiao Wang
HNHeyuan Niu
Heyuan Niu
Wenquan NiuWenquan Niu
Wenquan Niu
ZYZhiying Yang
Zhiying Yang
Backgrounds: Concomitant abdominal aortic aneurysms (AAA) and gastrointestinal malignancies are uncommon. Endovascular repair (EVAR) is widely used to treat AAA. However, no consensus exists on the optimal strategy for treating AAA when associated with pancreatic adenocarcinoma. In addition, only few reports of pancreaticoduodenectomy (PD) after EVAR exist. Presentation of case: A pancreatic tumor was detected during follow-up after EVAR for AAA in an 83-year-old female patient. The diagnosis was high-grade intraepithelial neoplasia. Modified pylorus-preserving pancreaticoduodenectomy was safely performed. The patient recovered moderately and was discharged two weeks after surgery. The pathological diagnosis was middle-grade pancreatic ductal adenocarcinoma. The patient survived for 24 months with no recurrence or cardiovascular complications. Conclusions: Conducting periodic follow-ups after AAA surgery is helpful for the early discovery of gastrointestinal tumors. EVAR surgery is safe and feasible and thus recommended for AAA patients with pancreatic cancer, although it may increase the risk of cancer. The stage of malignancy and post-EVAR medical history can be valuable in evaluating the benefits of pancreatic surgery for such cases.

4 June 2026 in Future Science OA
Verified
Journal Article
Open access
XLXiaoping Li
Xiaoping Li
HDHaipeng Du
Haipeng Du
QLQiuyu Liao
Qiuyu Liao
ZZZhenyu Zhu
Zhenyu Zhu
HNHeyuan Niu
Heyuan Niu
GLGang Liu
Gang Liu
Early-onset colorectal cancer (EOCRC) shows a rising global incidence with distinct epidemiological features from late-onset colorectal cancer (LOCRC). This study aimed to compare the epidemiological patterns and temporal trends of EOCRC and LOCRC from 1990 to 2021 based on the Global Burden of Disease (GBD) 2021 dataset. We analyzed the incidence, prevalence, mortality, and DALYs of EOCRC and LOCRC across 204 countries using the GBD 2021 dataset. Age-standardized rates (ASRs), estimated annual percentage changes (EAPCs), and socio-demographic index (SDI) stratifications were applied. Projections to 2040 were performed using Bayesian modeling. In 2021, LOCRC remained dominant (1.98 million vs. 212,000 cases), but EOCRC exhibited a faster incidence increase (EAPC: 0.37 vs. 0.13). Males were predominant, particularly in cases of EOCRC. Higher SDI was generally associated with higher incidence, though LOCRC declined in regions with SDI >0.85. The rise in EOCRC burden was primarily driven by aging, while population growth drove LOCRC. Projections indicate that ASRs of EOCRC will peak then decrease, whereas LOCRC will continue to rise. LOCRC remains dominant globally, but the rapid increase in EOCRC requires urgent public health action. Age-specific strategies are needed: optimized screening for the elderly to control LOCRC and strengthened risk factor management in young populations to reduce EOCRC.

29 September 2024
Verified
Dataset
Closed access
PDF file
MZMaorun Zhang
Maorun Zhang
TYTao Yu
Tao Yu
JJJinyan Jia
Jinyan Jia
QZQi Zhang
Qi Zhang
HNHeyuan Niu
Heyuan Niu
GLGang Liu
Gang Liu
Cancer-specific survival (CSS) in multiple primary colorectal cancer (MPCC) patients is competitively affected by death from other causes. This study ...

27 September 2024 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
MZMaorun Zhang
Maorun Zhang
TYTao Yu
Tao Yu
JJJinyan Jia
Jinyan Jia
QZQi Zhang
Qi Zhang
HNHeyuan Niu
Heyuan Niu
GLGang Liu
Gang Liu
Cancer-specific survival (CSS) in multiple primary colorectal cancer (MPCC) patients is competitively affected by death from other causes. This study ...

7 September 2026 in Discover Oncology
Verified
Journal Article
Open access
PDF file
WLWenzhen Liu
Wenzhen Liu
TYTao Yu
Tao Yu
YSYulin Song
Yulin Song
ZLZijun Liu
Zijun Liu
JQJinyang Qi
Jinyang Qi
GLGang Liu
Gang Liu
Background Tumor metastasis is the process by which tumor cells spread from the primary tumor to distant organs. This process is not random. Different tumor types often tend to spread to specific organs. This phenomenon is known as tumor metastatic organotropism. This study aimed to systematically analyze global research trends and insights into tumor metastatic organotropism, focusing on key mechanisms and treatment strategies to support future advances. Methods The Web of Science Core Collection was searched for documents from its inception in 1974 to 28 September, 2025. Bibliometric analyses and visualizations were conducted using VOSviewer, CiteSpace, Bibliometrix, R, Scimago Graphica, and Pajek. The analysis mainly covered publication trends, countries, institutions, journals, authors, cited references, and keywords. These elements were used to uncover internal structures and interconnections within the field. Results A total of 7,206 authors from 1,566 institutions across 75 countries contributed 1088 papers on tumor metastatic organotropism published in 486 journals. Global research on tumor metastatic organotropism has shown steady and significant growth. Most publications originated from the United States, China, and Germany. Notably, the United States had the highest number of publications, citation counts, and contributing institutions. Memorial Sloan Kettering Cancer Center had the highest institutional publication output in this field. Cancer published the highest number of articles, whereas Cancer Research received the most citations (2,811). Yibin Kang had the highest publication output among the identified authors, contributing fifteen publications. Among the types of cancer metastasis, research on trends in breast, lung, and colorectal cancers is relatively prevalent. Keyword co-occurrence and citation burst analyses identified the pre-metastatic niche, exosomes, and immunotherapy as prominent topics in the analyzed study. Conclusions This bibliometric study offers a comprehensive overview of the current landscape of tumor metastatic organotropism research. By summarizing the current situation in this field and identifying research trends, this study may provide useful insights and references for researchers aiming to effectively prevent and treat tumor metastatic organotropism in the future.

1 July 2026 in Discover Oncology
Verified
Journal Article
Open access
YSYulin Song
Yulin Song
ZZZhenyu Zhu
Zhenyu Zhu
YDYan Daijun
Yan Daijun
XFXingcan Fan
Xingcan Fan
QLQiuyu Liao
Qiuyu Liao
GLGang Liu
Gang Liu
Cancer continues to pose a significant global health challenge, with numerous tumors still being identified at advanced stages despite considerable advancements in therapeutic interventions and imaging methodologies. Model organisms play a crucial role in elucidating tumor biology, identifying therapeutic targets, and assessing drug efficacy and toxicity. C. elegans, a simple but genetically tractable metazoan with extensive pathway conservation, is an important model in oncology. However, a comprehensive bibliometric overview of C. elegans in cancer research remains absent. This study aimed to map the knowledge structure and identify research hotspots and frontiers in this field. We retrieved publications on C. elegans and cancer from the Web of Science Core Collection (WoSCC) and Scopus. Country/region and institutional contributions, authorship, journal sources, co-citation networks, and keyword co-occurrence patterns, were systematically visualized and analyzed utilizing VOSviewer, CiteSpace, Scimago Graphica, and Pajek. A total of 5007 publications related to C. elegans and cancer were identified, originating from 93 countries/regions, 4,680 institutions, and 1,364 journals. The United States contributed the largest share of outputs and citations, followed by several major European and Asian countries, forming dense international collaboration networks. Co-citation and journal analyses indicated that genetics, cell biology, and oncology constitute the core disciplinary hubs of this field. The analysis of keyword co-occurrence and temporal evolution indicates a transition from fundamental research on conserved signaling pathways, such as RAS, p53, and let-7, as well as stress response mechanisms, to a focus on tumor-centric applications. This shift encompasses the development of model-based anti-cancer drug development and emerging strategies for early cancer detection. This bibliometric analysis elucidates the global landscape and dynamic evolution of C. elegans in cancer research. Our findings highlight the growing role of C. elegans in the literature at the intersection of fundamental cancer biology, high-throughput drug discovery, and emerging diagnostic-related research directions. Future work is likely to focus on mechanism-driven target identification, integrated phenotypic and multi-omics screening, and AI-enabled chemotaxis-based approaches for cancer-related detection research and potential precision-oncology-associated applications.